Dare Bioscience, Inc. Deferred Tax Assets, Operating Loss Carryforwards
Dare Bioscience, Inc. (DARE) had Deferred Tax Assets, Operating Loss Carryforwards of $98.46 million as of 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-03-26
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $98.46M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $85.69M; Deferred Tax Assets, Operating Loss Carryforwards as first filed $86.59M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $86.18M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $81.76M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards | Deferred Tax Assets, Operating Loss Carryforwards as first filed |
|---|---|---|
| 2025-12-31 | $98.46M 10-K · filed 2026-03-26 | |
| 2024-12-31 | $85.69M 10-K · filed 2026-03-26 | $86.59M 10-K · filed 2025-03-31 |
| 2023-12-31 | $86.18M 10-K · filed 2025-03-31 | |
| 2022-12-31 | $81.76M 10-K · filed 2024-03-28 | |
| 2021-12-31 | $81.82M 10-K · filed 2023-03-30 | |
| 2020-12-31 | $68.44M 10-K · filed 2022-03-31 | |
| 2019-12-31 | $46.12M 10-K · filed 2021-03-30 | |
| 2018-12-31 | $40.44M 10-K · filed 2020-03-27 | |
| 2017-12-31 | $32.41M 10-K · filed 2019-04-01 | |
| 2016-12-31 | $290.00K 10-K · filed 2018-03-28 | $42.21K 10-K · filed 2017-03-31 |
| 2015-12-31 | $35.80M 10-K/A · filed 2017-06-13 | $35.80K 10-K · filed 2017-03-31 |
| 2015-12-15 | $35.80K 10-K · filed 2016-03-10 | |
| 2014-12-31 | $29.44K 10-K · filed 2016-03-10 | |
| 2013-12-31 | $25.70K 10-K · filed 2015-03-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Theriva Biologics, Inc. (TOVX) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |